MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
SILO Silo Pharma
- 0.878
- +0.043+5.16%
Close Dec 20 16:00 ET
- 0.879
- +0.001+0.09%
Post 19:48 ET
3.94MMarket Cap-0.76P/E (TTM)
0.895High0.835Low95.00KVolume0.835Open0.835Pre Close82.12KTurnover2.34%Turnover RatioLossP/E (Static)4.48MShares4.50052wk High0.58P/B3.57MFloat Cap0.77052wk Low--Dividend TTM4.06MShs Float19.500Historical High--Div YieldTTM7.16%Amplitude0.770Historical Low0.864Avg Price1Lot Size
Silo Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -25.63%-1.35M | -33.06%-731.8K | -21.00%-838.18K | 7.81%-3.22M | -2.71%-910.01K | 24.64%-1.07M | -37.45%-549.97K | 12.23%-692.69K | -55.24%-3.5M | -14.49%-885.99K |
| Net income from continuing operations | -40.70%-928.81K | 8.01%-931.78K | 11.55%-801.67K | 5.32%-3.7M | 32.57%-1.12M | 32.86%-660.16K | -53.85%-1.01M | -50.05%-906.4K | -200.12%-3.91M | -52.74%-1.66M |
| Operating gains losses | --0 | --1.26K | ---234 | ---- | ---- | ---- | ---- | ---- | 101.57%104.7K | --0 |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | --33.78K | 139.40%33.78K | -5,420.48%-85.73K | --0 |
| Change In working capital | 4.43%-420.78K | -52.61%198.72K | -120.60%-36.28K | 497.51%299.28K | -77.54%144.19K | 11.21%-440.29K | 546.59%419.29K | 161.53%176.09K | -110.32%-75.29K | 143.01%641.9K |
| -Change in receivables | --0 | --0 | --0 | 25.21%-3.59K | --0 | 0.00%-1.21K | -0.08%-1.2K | 0.08%-1.18K | -296.69%-4.8K | 0.00%-1.21K |
| -Change in prepaid assets | -712.26%-124.71K | -70.54%14.94K | -15.45%-116.33K | -35.49%35.7K | -87.82%65.4K | 103.92%20.37K | -53.04%50.7K | -44.64%-100.77K | 242.39%55.34K | 599.92%537.01K |
| -Change in payables and accrued expense | 37.01%-278.05K | -47.96%201.81K | -66.87%98.08K | 731.54%339.27K | -22.00%96.82K | -1,118.30%-441.42K | 1,722.43%387.81K | 250.06%296.06K | -118.46%-53.72K | -39.94%124.12K |
| -Change in other working capital | 0.00%-18.03K | 0.00%-18.03K | 0.00%-18.03K | 0.00%-72.1K | -0.01%-18.03K | 0.01%-18.03K | 0.01%-18.03K | -0.01%-18.03K | -115.06%-72.1K | 0.01%-18.03K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -25.63%-1.35M | -33.06%-731.8K | -21.00%-838.18K | 7.81%-3.22M | -2.71%-910.01K | 24.64%-1.07M | -37.45%-549.97K | 12.23%-692.69K | -53.54%-3.5M | -14.49%-885.99K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -103.21%-40.43K | 124.94%954.27K | 101.62%97.6K | -4,882.90%-4.15M | 4.43M | 1.26M | -5,835.90%-3.83M | -30,141.70%-6.01M | -98.79%86.71K | 0 |
| Net investment purchase and sale | -103.21%-40.43K | 124.94%954.27K | 101.62%97.6K | -6,316.90%-4.15M | --4.43M | --1.26M | -5,835.90%-3.83M | ---6.01M | -99.05%66.71K | --0 |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -88.37%20K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -103.21%-40.43K | 124.94%954.27K | 101.62%97.6K | -4,882.90%-4.15M | --4.43M | --1.26M | -5,835.90%-3.83M | -30,141.70%-6.01M | -98.79%86.71K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,294.96%1.74M | 1,333.64%1.62M | -115.45K | -109.54%-471.12K | -194.42K | -102.95%-145.74K | -130.96K | 0 | 30.23%4.94M | 0 |
| Net common stock issuance | 1,294.96%1.74M | 1,333.63%1.62M | ---115.45K | -109.54%-471.12K | ---194.42K | -102.95%-145.74K | ---130.96K | --0 | --4.94M | --0 |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,294.96%1.74M | 1,333.64%1.62M | ---115.45K | -109.54%-471.12K | ---194.42K | -102.95%-145.74K | ---130.96K | --0 | 30.23%4.94M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 2,737.15%4.51M | -42.81%2.67M | -69.00%3.52M | 15.55%11.37M | -98.37%199.84K | -98.18%158.83K | -48.54%4.67M | 15.55%11.37M | 771.77%9.84M | 19.41%12.25M |
| Current changes in cash | 764.71%354.59K | 140.78%1.84M | 87.23%-856.04K | -612.59%-7.84M | 475.23%3.32M | -98.83%41.01K | -1,251.87%-4.51M | -771.21%-6.7M | -82.43%1.53M | -108.76%-885.99K |
| End cash Position | 2,332.40%4.86M | 2,737.15%4.51M | -42.81%2.67M | -69.00%3.52M | -69.00%3.52M | -98.37%199.84K | -98.18%158.83K | -48.54%4.67M | 15.55%11.37M | 15.55%11.37M |
| Free cash flow | -25.63%-1.35M | -33.06%-731.8K | -21.00%-838.18K | 7.81%-3.22M | -2.71%-910.01K | 24.64%-1.07M | -37.45%-549.97K | 12.23%-692.69K | -53.54%-3.5M | -14.49%-885.99K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.